Cargando…

A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder

BACKGROUND: To elucidate the genetic basis of a novel neurodegenerative disorder in an Old Order Amish pedigree by combining homozygosity mapping with exome sequencing. METHODS AND RESULTS: We identified four individuals with an autosomal recessive condition affecting the central nervous system (CNS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahiry, Piya, Racacho, Lemuel, Wang, Jian, Robinson, John F, Gloor, Gregory B, Rupar, C Anthony, Siu, Victoria M, Bulman, Dennis E, Hegele, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765793/
https://www.ncbi.nlm.nih.gov/pubmed/23957953
http://dx.doi.org/10.1186/1750-1172-8-126
_version_ 1782283392236126208
author Lahiry, Piya
Racacho, Lemuel
Wang, Jian
Robinson, John F
Gloor, Gregory B
Rupar, C Anthony
Siu, Victoria M
Bulman, Dennis E
Hegele, Robert A
author_facet Lahiry, Piya
Racacho, Lemuel
Wang, Jian
Robinson, John F
Gloor, Gregory B
Rupar, C Anthony
Siu, Victoria M
Bulman, Dennis E
Hegele, Robert A
author_sort Lahiry, Piya
collection PubMed
description BACKGROUND: To elucidate the genetic basis of a novel neurodegenerative disorder in an Old Order Amish pedigree by combining homozygosity mapping with exome sequencing. METHODS AND RESULTS: We identified four individuals with an autosomal recessive condition affecting the central nervous system (CNS). Neuroimaging studies identified progressive global CNS tissue loss presenting early in life, associated with microcephaly, seizures, and psychomotor retardation; based on this, we named the condition Autosomal Recessive Cerebral Atrophy (ARCA). Using two unbiased genetic approaches, homozygosity mapping and exome sequencing, we narrowed the candidate region to chromosome 11q and identified the c.995C > T (p.Thr332Met) mutation in the TMPRSS4 gene. Sanger sequencing of additional relatives confirmed that the c.995C > T genotype segregates with the ARCA phenotype. Residue Thr332 is conserved across species and among various ethnic groups. The mutation is predicted to be deleterious, most likely due to a protein structure alteration as demonstrated with protein modelling. CONCLUSIONS: This novel disease is the first to demonstrate a neurological role for a transmembrane serine proteases family member. This study demonstrates a proof-of-concept whereby combining exome sequencing with homozygosity mapping can find the genetic cause of a rare disease and acquire better understanding of a poorly described protein in human development.
format Online
Article
Text
id pubmed-3765793
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37657932013-09-08 A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder Lahiry, Piya Racacho, Lemuel Wang, Jian Robinson, John F Gloor, Gregory B Rupar, C Anthony Siu, Victoria M Bulman, Dennis E Hegele, Robert A Orphanet J Rare Dis Research BACKGROUND: To elucidate the genetic basis of a novel neurodegenerative disorder in an Old Order Amish pedigree by combining homozygosity mapping with exome sequencing. METHODS AND RESULTS: We identified four individuals with an autosomal recessive condition affecting the central nervous system (CNS). Neuroimaging studies identified progressive global CNS tissue loss presenting early in life, associated with microcephaly, seizures, and psychomotor retardation; based on this, we named the condition Autosomal Recessive Cerebral Atrophy (ARCA). Using two unbiased genetic approaches, homozygosity mapping and exome sequencing, we narrowed the candidate region to chromosome 11q and identified the c.995C > T (p.Thr332Met) mutation in the TMPRSS4 gene. Sanger sequencing of additional relatives confirmed that the c.995C > T genotype segregates with the ARCA phenotype. Residue Thr332 is conserved across species and among various ethnic groups. The mutation is predicted to be deleterious, most likely due to a protein structure alteration as demonstrated with protein modelling. CONCLUSIONS: This novel disease is the first to demonstrate a neurological role for a transmembrane serine proteases family member. This study demonstrates a proof-of-concept whereby combining exome sequencing with homozygosity mapping can find the genetic cause of a rare disease and acquire better understanding of a poorly described protein in human development. BioMed Central 2013-08-17 /pmc/articles/PMC3765793/ /pubmed/23957953 http://dx.doi.org/10.1186/1750-1172-8-126 Text en Copyright © 2013 Lahiry et al.; licensee BioMed Central Ltd. http://www.creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://www.creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lahiry, Piya
Racacho, Lemuel
Wang, Jian
Robinson, John F
Gloor, Gregory B
Rupar, C Anthony
Siu, Victoria M
Bulman, Dennis E
Hegele, Robert A
A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
title A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
title_full A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
title_fullStr A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
title_full_unstemmed A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
title_short A mutation in the serine protease TMPRSS4 in a novel pediatric neurodegenerative disorder
title_sort mutation in the serine protease tmprss4 in a novel pediatric neurodegenerative disorder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765793/
https://www.ncbi.nlm.nih.gov/pubmed/23957953
http://dx.doi.org/10.1186/1750-1172-8-126
work_keys_str_mv AT lahirypiya amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT racacholemuel amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT wangjian amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT robinsonjohnf amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT gloorgregoryb amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT ruparcanthony amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT siuvictoriam amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT bulmandennise amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT hegeleroberta amutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT lahirypiya mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT racacholemuel mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT wangjian mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT robinsonjohnf mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT gloorgregoryb mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT ruparcanthony mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT siuvictoriam mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT bulmandennise mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder
AT hegeleroberta mutationintheserineproteasetmprss4inanovelpediatricneurodegenerativedisorder